Jump to content

  • Log in with Facebook Log in with Twitter Log In with Google Sign In
  • Create Account

Support, help, advice & information for Multiple Sclerosis. Ask questions & share experiences with people affected by MS.

#NewsSpeak: MS-STAT2 finally takes-off

  • You cannot start a new topic
  • Please log in to reply
No replies to this topic

RSS News

RSS News

    RSS News Feed Reader

  • Staff
  • 5,611 posts
  • Joined: 25-May 08
    Member: 792
  • Gender:Not Telling

Current mood: None chosen
Finally a phase 3 trial in progressive MS is being done outside of Big Pharma. #NewsSpeak #MSBlog

MS-STAT2 takes-off
Great news for people with progressive MS. We will now get an answer about whether or not simvastatin works in a larger study, its safety profile and more importantly its risk:benefit profile in people with more advanced MS. This study may give us clues about how simvastatin is working; is it working via comorbidities or specific anti-inflammatory or neuroprotective mechanisms? 

Have we learnt our lessons about drug repurposing? If positive will this trial lead to a regulatory submission and label extension for simvastatin? Who will manage the regulatory submission? Who will maintain the license? Will one phase 3 trial be sufficient? Will the regulators want more data on a dose-response? Will a regulatory submission be necessary? If simvastatin goes unlicensed for MS will the wider community adopt it? How will it be used in clinical practice; as a monotherapy or add-on to all other DMTs? How will Pharma respond? All these questions will only need to be answered if the trial is positive; so let's find out. 

Congratulations to Jeremy Chataway and the team who pulled this together. Getting trials like this designed, costed and funded is no easy task, particularly when you see the number of partners. Well done! Pharma must be asking how academia can run trials of this size and complexity so cheaply. May be the Pharma machine has become too complex? 

<iframe allowfullscreen="" class="YOUTUBE-iframe-video" data-thumbnail-src="https://i.ytimg.com/vi/MDLQBtcOie4/0.jpg" frameborder="0" height="266" src="https://www.youtube.com/embed/MDLQBtcOie4?feature=player_embedded" width="320"></iframe>

<iframe allowfullscreen="" frameborder="0" height="940" marginheight="0" marginwidth="0" scrolling="no" src="//www.slideshare.net/slideshow/embed_code/key/6gDdTUL6mtZGp8" style="border-width: 1px; border: 1px solid #ccc; margin-bottom: 5px; max-width: 100%;" width="680"> </iframe>

CoI: Barts-MS are a partner organisation in the MS-STAT2 trial

View the full article

0 user(s) are reading this topic

0 members, 0 guests, 0 anonymous users

The MS People Forum is not responsible for advice or information supplied by members. We suggest you seek medical advice before trying anything.
Messages posted within the Forum express only the views of the author of the message and do not necessarily reflect the views of MS-People.com.
MS-People.com nor any person or entity associated with them will be held responsible for the contents, accuracy, completeness or validity of any information posted on the site.